Therapeutic Potential of Targeting Wnt/-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress

被引:162
作者
Bahrami, Afsane [1 ]
Amerizadeh, Forouzan [1 ]
ShahidSales, Soodabeh [4 ]
Khazaei, Majid [5 ]
Ghayour-Mobarhan, Majid [4 ]
Sadeghnia, Hamid Reza [1 ]
Maftouh, Mina [3 ]
Hassanian, Seyed Mahdi [2 ,3 ]
Avan, Amir [3 ,4 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Modern Sci & Technol, Mashhad, Iran
[2] Mashhad Univ Med Sci, Sch Med, Dept Med Biochem, Mashhad, Iran
[3] Mashhad Univ Med Sci, Sch Med, Metab Syndrome Res Ctr, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Med, Canc Res Ctr, Mashhad, Iran
[5] Mashhad Univ Med Sci, Neurogen Inflammatory Res Ctr, Dept Physiol, Mashhad, Iran
关键词
COLON CANCER; Wnt; -CATENIN; INHIBITOR; THERAPEUTIC TARGET; SMALL-MOLECULE INHIBITOR; BETA-CATENIN; COLON-CANCER; STEM-CELLS; SIGNALING PATHWAY; PDZ DOMAIN; E-CADHERIN; ACTIVATION; EXPRESSION; DIFFERENTIATION;
D O I
10.1002/jcb.25903
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Wnt/-catenin pathway is one of the main/frequent dysregulated pathways in several tumor types, including colon cancer. Aberrant activation of this pathway is associated with cell proliferation, invasive behaviors, and cell resistance, suggesting its potential value as a therapeutic target in treatment of CRC. Several agents have been developed for targeting of this pathway (e.g, natural agents: curcumin, 3,3-diindolylmethane, phytoestrogen; Synthetic/small Wnt inhibitors: Rofecoxib; PRI-724, CWP232291; and monoclonal antibody against frizzled receptors, Vanituctumab). This review summarizes the current knowledge about the therapeutic potential of targeting Wnt pathway with particular emphasis on preclinical/clinical studies in treatment of colorectal cancer. J. Cell. Biochem. 118: 1979-1983, 2017. (c) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:1979 / 1983
页数:5
相关论文
共 49 条
[1]
Arun B, 2004, ROLE COX 2 INHIBITIO, P22
[2]
Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1
[3]
Regulation of Wnt protein secretion and its role in gradient formation [J].
Bartscherer, Kerstin ;
Boutros, Michael .
EMBO REPORTS, 2008, 9 (10) :977-982
[4]
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer [J].
Chen, Baozhi ;
Dodge, Michael E. ;
Tang, Wei ;
Lu, Jianming ;
Ma, Zhiqiang ;
Fan, Chih-Wei ;
Wei, Shuguang ;
Hao, Wayne ;
Kilgore, Jessica ;
Williams, Noelle S. ;
Roth, Michael G. ;
Amatruda, James F. ;
Chen, Chuo ;
Lum, Lawrence .
NATURE CHEMICAL BIOLOGY, 2009, 5 (02) :100-107
[5]
Ciombor KK, 2015, PHASE 1B 2 STUDY CAN, P3617
[6]
Recent Therapeutic Advances in the Treatment of Colorectal Cancer [J].
Ciombor, Kristen K. ;
Wu, Christina ;
Goldberg, Richard M. .
ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 :83-95
[7]
ICG-001, A Novel Small Molecule Regulator of TCF/β-Catenin Transcription [J].
Eguchi, Masakatsu ;
Cu Nguyen ;
Lee, Sung Chan ;
Kahn, Michael .
MEDICINAL CHEMISTRY, 2005, 1 (05) :467-472
[8]
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription [J].
Emami, KH ;
Nguyen, C ;
Ma, H ;
Kim, DH ;
Jeong, KW ;
Eguchi, M ;
Moon, RT ;
Teo, JL ;
Oh, SW ;
Kim, HY ;
Moon, SH ;
Ha, JR ;
Kahn, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12682-12687
[9]
Wnt/β-catenin signaling in cancer stemness and malignant behavior [J].
Fodde, Riccardo ;
Brabletz, Thomas .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) :150-158
[10]
An antagonist of dishevelled protein-protein interaction suppresses β-catenin-dependent tumor cell growth [J].
Fujii, Naoaki ;
You, Liang ;
Xu, Zhidong ;
Uematsu, Kazutsugu ;
Shan, Jufang ;
He, Biao ;
Mikami, Iwao ;
Edmondson, Lillian R. ;
Neale, Geoffrey ;
Zheng, Jie ;
Guy, R. Kiplin ;
Jablons, David M. .
CANCER RESEARCH, 2007, 67 (02) :573-579